Palliative Medicine in Practice最新文献

英文中文

Perception of patients with COVID-19 about respecting their dignity in hospital settings: a cross-sectional study 新冠肺炎患者在医院环境中尊重尊严的认知：一项横断面研究

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2023-01-17 DOI: 10.5603/pmpi.a2023.0005

S. Bathaei, Iman Khahan Yazdi, Alireza Mirbagheri Gam, Maryam Naghipoor Far

引用次数: 0

Palliative care knowledge among final year medicine & health sciences students: a cross-sectional study 医学与健康科学专业大四学生的姑息治疗知识：一项横断面研究

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2023-01-16 DOI: 10.5603/pmpi.a2023.0003

Kamala Krishnan, Muhammad Noh Zulfikri Mohd Jamali, Tan Wei Wern

引用次数: 0

Audit on bedside chemical pleurodesis in palliative care setting: Brunei experience 姑息治疗环境中床边化学胸膜固定术的审计：文莱经验

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2023-01-16 DOI: 10.5603/pmpi.a2023.0004

Muhammad Yusuf Shaharudin

引用次数: 0

Safe practices for legitimate medical use of opioids: a study of trends in opioids prescription over a decade 阿片类药物合法医疗使用的安全做法：十年来阿片类处方趋势研究

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2023-01-13 DOI: 10.5603/pmpi.a2023.0002

引用次数: 0

An international study of healthcare professionals’ understandings of palliative care 医疗专业人员对姑息治疗理解的国际研究

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.a2022.0021

D. Oliver, R. Forrester-Jones

引用次数: 0

Qualifications, competencies and professional liability of palliative care nurses 姑息治疗护士的资格、能力和专业责任

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.a2022.0020

Agata Panas

引用次数: 1

Quality of life of palliative care cancer patients during COVID-19 lockdown phase 新冠肺炎封锁阶段癌症姑息治疗患者的生活质量

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.a2022.0022

S. Adhikari, A. Pandit, Bhawesh Pangaria, S. Bhatnagar

Background: Coronavirus pandemic in 2019 led India to implement a complete lockdown except for essential services. Cancer patients faced hindrances in seeking medical help. This caused stress and worry, leading to reduced quality of life (QoL). This study evaluated QoL and pain management in palliative care cancer patients during the lockdown. Patients and Methods: This was a cross-sectional observational study at a tertiary cancer hospital, over one month period with convenience sampling. Participants included all who were unable to visit the palliative outpatient department during the lockdown during the COVID-19 pandemic. They were contacted telephonically and a valid QoL questionnaire was filled out. Disease, demographic details and pain were assessed. Result(s): A total of 51 were interviewed, 45% (n = 23) patients reported difficult access to medication during the lockdown;18 (35.3%) required morphine to alleviate pain and 6 (33.33%) faced difficulty in acquiring morphine tablets. QoL scores did not differ based on access to morphine (p = 0.648). Mean QoL scores were 12.7 +/- 3.76 and 15.0 +/- 3.60 amongst patients who did not have access to other medications and those who did have access, respectively (p = 0.03). Overall QoL FACT G7 mean score was 14 +/- 3.8. The variables NRS (pain intensity) and QoL scores were found to be negatively correlated (Pearson's Correlation Coefficient: r (49) = -0.69, p < 0.00001). Conclusion(s): Evaluation of QoL of palliative care cancer patients during global crises plays an important role in the assessment of patients' overall condition as well as to maintain a continuum of care.Copyright © Via Medica.

背景：2019年的冠状病毒大流行导致印度实施了除基本服务外的全面封锁。癌症患者在寻求医疗帮助方面面临障碍。这造成了压力和担忧，导致生活质量下降。这项研究评估了癌症姑息治疗患者在封锁期间的生活质量和疼痛管理。患者和方法：这是一项在癌症三级医院进行的横断面观察性研究，为期一个月，方便抽样。参与者包括在新冠肺炎大流行期间封锁期间无法前往姑息门诊的所有人。他们通过电话联系，并填写了有效的生活质量问卷。对疾病、人口统计细节和疼痛进行了评估。结果：共采访了51名患者，45%（n=23）的患者报告在封锁期间难以获得药物；18人（35.3%）需要吗啡来缓解疼痛，6人（33.33%）难以获得吗啡片。根据吗啡的使用情况，生活质量得分没有差异（p=0.648）。在没有使用其他药物的患者和有使用药物的患者中，平均生活质量得分分别为12.7+/-3.76和15.0+/-3.60（p=0.03）。总体生活质量FACT G7平均分为14+/-3.8。变量NRS（疼痛强度）和生活质量评分呈负相关（Pearson相关系数：r（49）=-0.69，p<0.00001）。版权所有©Via Medica。

{"title":"Quality of life of palliative care cancer patients during COVID-19 lockdown phase","authors":"S. Adhikari, A. Pandit, Bhawesh Pangaria, S. Bhatnagar","doi":"10.5603/pmpi.a2022.0022","DOIUrl":"https://doi.org/10.5603/pmpi.a2022.0022","url":null,"abstract":"Background: Coronavirus pandemic in 2019 led India to implement a complete lockdown except for essential services. Cancer patients faced hindrances in seeking medical help. This caused stress and worry, leading to reduced quality of life (QoL). This study evaluated QoL and pain management in palliative care cancer patients during the lockdown. Patients and Methods: This was a cross-sectional observational study at a tertiary cancer hospital, over one month period with convenience sampling. Participants included all who were unable to visit the palliative outpatient department during the lockdown during the COVID-19 pandemic. They were contacted telephonically and a valid QoL questionnaire was filled out. Disease, demographic details and pain were assessed. Result(s): A total of 51 were interviewed, 45% (n = 23) patients reported difficult access to medication during the lockdown;18 (35.3%) required morphine to alleviate pain and 6 (33.33%) faced difficulty in acquiring morphine tablets. QoL scores did not differ based on access to morphine (p = 0.648). Mean QoL scores were 12.7 +/- 3.76 and 15.0 +/- 3.60 amongst patients who did not have access to other medications and those who did have access, respectively (p = 0.03). Overall QoL FACT G7 mean score was 14 +/- 3.8. The variables NRS (pain intensity) and QoL scores were found to be negatively correlated (Pearson's Correlation Coefficient: r (49) = -0.69, p < 0.00001). Conclusion(s): Evaluation of QoL of palliative care cancer patients during global crises plays an important role in the assessment of patients' overall condition as well as to maintain a continuum of care.Copyright © Via Medica.","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48034897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Risk of reoperation for anastomotic leakage after anterior resection of rectal cancer after neoadjuvant therapy 直肠癌前切除术后新辅助治疗后吻合口漏再手术的风险分析

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.a2022.0016

K. Osowiecka, Anna Sugajska, Maciej Biernacki, S. Nawrocki, M. Rucińska

引用次数: 0

Report of the First Conference in Zielona Góra: Palliative medicine, supportive care and pain management in patients with non-cancer diseases Zielona第一次会议报告Góra:非癌症疾病患者的姑息医学、支持性护理和疼痛管理

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.2022.0031

Grzegorz Loroch, W. Leppert

引用次数: 1

Website information on visiting policies at specialist in-patient palliative care settings during COVID-19 pandemic across Central and Eastern Europe: a quantitative and qualitative study 关于中欧和东欧2019冠状病毒病大流行期间专科住院姑息治疗机构就诊政策的网站信息:一项定量和定性研究

Q4 Medicine

Palliative Medicine in Practice

Pub Date : 2022-12-28 DOI: 10.5603/pmpi.a2022.0023

Filip Lebiedziński, L. Pawłowski, Joanna Jastrzębska, Alicja Świątek, M. Lichodziejewska-Niemierko

Introduction: Since the COVID-19 pandemic, visiting policies in various healthcare centres across the world have changed. Visiting patients by relatives and friends have been stopped or significantly limited. New conditions and legal constraints for family visits had to be implemented also at in-patient palliative care settings, even though accompanying a dying person is crucial for the quality of the end of life. The study aimed to identify and review the visiting policies at in-patient specialist palliative care settings across Central and Eastern Europe. Patients and Methods: The study was conducted one year after the COVID-19 pandemic outbreak from May to October 2021. Information about visiting policies, published on official websites of the in-patient specialised palliative care settings (stationary hospices and hospital-based palliative care units) from Central and Eastern European countries, were identified and categorised. The websites which lacked information about visiting policy during the COVID-19 pandemic were excluded. Qualitative and quantitative analysis of the obtained data was conducted by using content analysis techniques and descriptive analysis. The content from websites was translated into Polish with the usage of the Google Translate machine tool. Result(s): Data from 55 in-patient palliative care settings from 8 countries were collected and analysed (83.6% from Poland, and the other from Bulgaria, Czech Republic, Estonia, Lithuania, Romania, Slovakia and Ukraine). In 43.6% of the organisations, visits were stopped and 56.4% of settings published information about the special requirements for visiting arrangements. In 32.7% of all examined units upfront approval from a physician or the head of a department for visiting a patient was required, and 29.1% published information about personal protective equipment. 32.7% of organizations recommended telephone contact with the patient, and 12.7% provided video calls. Conclusion(s): Web information regarding visiting patients in in-patient palliative care settings is limited. There is a need to establish detailed requirements for the visits with better access to the website for the visitors, in case of a global disease outbreak.Copyright © Via Medica, ISSN 2545-0425, e-ISSN: 2545-1359.

简介：自新冠肺炎大流行以来，世界各地各医疗中心的就诊政策发生了变化。亲属和朋友探访病人的活动已经停止或受到很大限制。住院姑息治疗机构也必须实施新的探亲条件和法律限制，尽管陪伴垂死的人对临终质量至关重要。该研究旨在确定和审查中欧和东欧住院专科姑息治疗机构的探视政策。患者和方法：该研究是在2021年5月至10月新冠肺炎大流行爆发一年后进行的。在中欧和东欧国家的住院专业姑息治疗机构（固定式医院和以医院为基础的姑息治疗单位）的官方网站上发布的关于探视政策的信息得到了识别和分类。新冠肺炎大流行期间缺乏访问政策信息的网站被排除在外。使用内容分析技术和描述性分析对获得的数据进行定性和定量分析。使用谷歌翻译工具将网站上的内容翻译成波兰语。结果：收集并分析了来自8个国家的55个住院姑息治疗机构的数据（83.6%来自波兰，另一个来自保加利亚、捷克共和国、爱沙尼亚、立陶宛、罗马尼亚、斯洛伐克和乌克兰）。43.6%的组织停止了访问，56.4%的组织发布了有关访问安排特殊要求的信息。在所有接受检查的单位中，32.7%的单位需要事先获得医生或部门负责人的批准才能探视患者，29.1%的单位公布了有关个人防护设备的信息。32.7%的组织建议与患者进行电话联系，12.7%的组织提供视频通话。结论：关于在住院姑息治疗环境中访问患者的网络信息是有限的。有必要制定详细的访问要求，以便在全球疾病爆发的情况下更好地访问网站。版权所有©Via Medica，ISSN 2545-0425，e-ISSN:2545-1359。

{"title":"Website information on visiting policies at specialist in-patient palliative care settings during COVID-19 pandemic across Central and Eastern Europe: a quantitative and qualitative study","authors":"Filip Lebiedziński, L. Pawłowski, Joanna Jastrzębska, Alicja Świątek, M. Lichodziejewska-Niemierko","doi":"10.5603/pmpi.a2022.0023","DOIUrl":"https://doi.org/10.5603/pmpi.a2022.0023","url":null,"abstract":"Introduction: Since the COVID-19 pandemic, visiting policies in various healthcare centres across the world have changed. Visiting patients by relatives and friends have been stopped or significantly limited. New conditions and legal constraints for family visits had to be implemented also at in-patient palliative care settings, even though accompanying a dying person is crucial for the quality of the end of life. The study aimed to identify and review the visiting policies at in-patient specialist palliative care settings across Central and Eastern Europe. Patients and Methods: The study was conducted one year after the COVID-19 pandemic outbreak from May to October 2021. Information about visiting policies, published on official websites of the in-patient specialised palliative care settings (stationary hospices and hospital-based palliative care units) from Central and Eastern European countries, were identified and categorised. The websites which lacked information about visiting policy during the COVID-19 pandemic were excluded. Qualitative and quantitative analysis of the obtained data was conducted by using content analysis techniques and descriptive analysis. The content from websites was translated into Polish with the usage of the Google Translate machine tool. Result(s): Data from 55 in-patient palliative care settings from 8 countries were collected and analysed (83.6% from Poland, and the other from Bulgaria, Czech Republic, Estonia, Lithuania, Romania, Slovakia and Ukraine). In 43.6% of the organisations, visits were stopped and 56.4% of settings published information about the special requirements for visiting arrangements. In 32.7% of all examined units upfront approval from a physician or the head of a department for visiting a patient was required, and 29.1% published information about personal protective equipment. 32.7% of organizations recommended telephone contact with the patient, and 12.7% provided video calls. Conclusion(s): Web information regarding visiting patients in in-patient palliative care settings is limited. There is a need to establish detailed requirements for the visits with better access to the website for the visitors, in case of a global disease outbreak.Copyright © Via Medica, ISSN 2545-0425, e-ISSN: 2545-1359.","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47748961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Palliative Medicine in Practice

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀